期刊文献+

活血调脂汤对冠心病PCI术后血液流变性及血脂的影响 被引量:2

Effect of Huoxue Tiaozhi Decoction on Hemorheological Parameters and Blood Lipids in Coronary Heart Disease Patients after PCI
原文传递
导出
摘要 目的:观察活血调脂汤对冠心病经皮冠状动脉介入术(PCI)后血液流变性及血脂的调节作用。方法:将符合纳入标准的60例PCI术后患者随机分为观察组、对照组各40例。2组患者均于PCI术后给予阿司匹林肠溶片、辛伐他汀片口服:阿司匹林肠溶片100 mg/次,2次/d;辛伐他汀片,40 mg/次,2次/d。观察组加用活血调脂汤,水煎分服,250 mL/次,2次/d。2组均以治疗1个月为1个疗程,各治疗2个疗程。观察2组血液流变学及血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)的变化情况。结果:全血高、中、低切黏度,血浆黏度、红细胞压积治疗后观察组分别为(3.52±0.62),(4.33±0.54),(7.18±1.55),(1.32±0.14)mPa.s,(3 443±5.54)%;对照组分别为(3.72±0.58),(4.52±0.64),(7.41±1.23),(1.41±0.15)mPa.s,(36.78±5.68)%。两组治疗后均明显改善(P<0.05),且观察组改善优于对照组(P<0.05)。TC,TG,LDL-C,HDL-C等指标治疗后观察组为(3.61±0.41),(2.31±0.52),(3.75±0.38),(1.95±0.26)mmol.L-1,对照组分别为(3.72±0.58),(4.52±0.64),(7.41±1.23),(1.41±0.15)mmol.L-1。两组治疗后均明显改善(P<0.05),且观察组改善优于对照组(P<0.05)。结论:活血调脂汤用于冠心病PCI术后可改善血液流变性学、血脂等各项检测指标,有利于降低PCI术后再狭窄发生率。 Objective:To observe effect of Huoxue Tiaozhi Decoction on blood rheology of blood lipid regulation in coronary heart disease patients after percutaneous coronary intervention(PCI).Method:With incorporated into standard in 60 cases of PCI patients were randomly divided into observation group and control group,40 cases in each.Two groups of patients after PCI were given aspirin enteric-coated tablets 100 mg,bid,simvastatin tablet:(40 mg,bid).Observation group was added with Huoxue Tiaozhi Decoction,boiling water service,250 mL/bid.The 2 groups were treated for 1 month as 1 course,2 courses as the treatment.Hemorheology and serum total cholesterol(TC),triglyceride(TG),low density lipoprotein(LDL-C),high density lipoprotein(HDL-C) were observed.Result:The blood high,medium,low shear viscosity,plasma viscosity,hematocrit in treatment group were(3.52±0.62),(4.33±0.54),(7.18±1.55),(1.32±0.14) mPa · s,(34.43±5.54)%;the control group were(3.72±0.58),(4.52±0.64),(7.41±1.23),(1.41± 0.15) mPa · s,(36.78±5.68)%.The two groups after treatment were significantly improved(P〈0.05),and the treat ment group was better than the control group(P〈0.05).TC,TG,LDL-C,HDL-C indexes after treatment in treatment group were(3.61±0.41),(2.31±0.52),(3.75±0.38),(1.95±0.26) mmol · L-1,those in the control group were(3.72±0.58),(4.52±0.64),(7.41±1.23),(1.41±0.15) mmol · L-1.The two groups after treatment were significantly improved(P〈0.05),and the treatment group was better than the control group(P〈0.05).Conclusion:Huoxue Tiaozhi decoction used in coronary heart disease patients after PCI can improve hemorheological paramenters,blood lipids,reduce the incidence of restenosis after PCI.
作者 蒋贵平
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第18期281-283,共3页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 冠心病 PCI术 活血调脂汤 血液流变学 血脂 coronary heart disease; PCI; Huoxue Tiaozhi decoction; hemorheology; blood lipid
  • 相关文献

参考文献6

二级参考文献36

  • 1汪晓松,朱清於,黄进,钱源澄,黄福林,汪俊军,庄一义.脂蛋白(a)在主动脉粥样硬化病变中的定位与定量研究[J].中华病理学杂志,1995,24(1):4-7. 被引量:5
  • 2徐凯,韩雅玲,荆全民,王守力,马颖艳,栾波,王祖禄,王冬梅.他汀类药物减少冠心病患者支架术后再狭窄的影响因素及意义[J].中国动脉硬化杂志,2005,13(5):607-609. 被引量:14
  • 3陈灏珠主编.内科学[M]:第三版[M].北京:人民卫生出版社,1995.263-264.
  • 4[8]Zhang WJ, Wojta J, Binder BR. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside Ⅳ down-regulates plasminogen activator inhibitor-1 and up-regulates tissue-type plasminogen activator expression. J Vasc Res 1997;34(4) :273-280.
  • 5Provost P, Tremblay J, Merhi Y, et al. Arterioscler Thromb Vasc Biol, 1997,17(9): 1806.
  • 6Stenberg P E, McEver R P, Shuman M A, et al. Aplateler alphagranule membrane protein( GMP- 140) is expressed on the plasma after activation[J ]. Cell Biology, 1985,101:880.
  • 7Blann A D, McCollum C N. Von willebrand factor, endothelial cell damage and atherosclerosis[J ]. Eur Vasc Surg, 1994,8:10.
  • 8Wagner D D. Cell biology of yon Willebrand factor [ J ]. Annu Rev Cell Biol, 1990,6 (2): 217 - 246.
  • 9Sadler J E. Biochemistry and genetics of yon Willebrand factor [ J ]. Annu Rev Cell Biol, 1998,67 (4): 395 - 424.
  • 10Danesh J,DPhil,Gollins R,Peto R.Lipoprotein(a) and coronary heart disease[J].Circulation,2000,102:1 082-085

共引文献3322

同被引文献24

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部